Name,CAS,Conc,Effecti,AC10µM,pi,Endpoint(s)
Tetrabutylammonium bromide,1643-19-2,5.4314154695336e-06,9.28347045194705e-06,5.85063042710978,9.57229426404685e-05,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
1-Hexyl-3-methylimidazolium bromide,85100-78-3,0,0,1.78268148034769,0,TOX21_AR_BLA_Antagonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
1-Benzylquinolinium chloride,15619-48-4,1.10845213663951e-07,1.00238698981926e-06,1.10581257328507,1.95352944164221e-06,NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_gOpiateK|NVS_GPCR_hM2|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rmAdra2B|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT
"1,1-Dimethylpiperidinium chloride",24307-26-4,2.43859470060692e-06,1.6845425927706e-05,1.44763018226575,4.29776477161287e-05,NVS_LGIC_rNNR_BungSens
1-Benzyl-3-methylimidazolium chloride,36443-80-8,3.32535640991853e-07,3.62742469942158e-07,9.16726516872641,5.86058832492665e-06,TOX21_RT_HEK293_GLO_40hr_viability
Methylene blue,61-73-4,2.21690427327902e-07,7.00155769043434e-06,0.316630151645797,3.90705888328443e-06,TOX21_MMP_rhodamine
Estrone,53-16-7,6.42902239250916e-06,4.43637691850254e-05,1.44916054487977,0.000113304707615248,BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Heptachlor epoxide B,1024-57-3,1.3633961280666e-05,0.000240128476641987,0.56777777760166,0.000240284121321992,BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI
Stilonium iodide,77257-42-2,6.65071281983706e-07,1.94812690632908e-06,3.41390121877081,1.17211766498533e-05,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability
"1-Butyl-2,3-dimethylimidazolium iodide",108203-70-9,3.48053970904806e-05,0.000100552786086333,3.46140554082681,0.000613408244675656,TOX21_RT_HEPG2_GLO_40hr_viability
Imidacloprid,138261-41-3,1.10845213663951e-07,2.3005941947036e-06,0.48181123780603,1.95352944164221e-06,NVS_LGIC_hNNR_NBungSens|#SiNS|SH-S5Y5 neurite outgrowth
"1,3-Dinitrobenzene",99-65-0,1.33014256396741e-05,0.000622934189385956,0.213528585624522,0.000234423532997066,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC|NVS_ENZ_rMAOBP
4-Nitropyridine-1-oxide,1124-33-0,2.60486252110285e-05,2.64668435381405e-05,9.84198405582089,0.00045907941878592,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability
"1,4-Dinitrobenzene",100-25-4,0.000189323624938028,0.000212848608598433,8.89475511184627,0.0033366282863249,BSK_3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PXR_viability
"1-Fluoro-2,4-dinitrobenzene",70-34-8,2.4940173074389e-05,0.000721504671195282,0.345668906523804,0.000439544124369498,TOX21_MMP_ratio_down
"1,8-Dinitronaphthalene",602-38-0,2.77113034159878e-05,0.000133788440216472,2.07127786011634,0.000488382360410554,TOX21_MMP_rhodamine
1-Methyl-3-hexylimidazolium trifluoromethylsulfonate,460345-16-8,0,0,3.95579295369595,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Brolamfetamine hydrobromide,53581-53-6,1.10845213663951e-07,2.41965460545576e-07,4.58103455815639,1.95352944164221e-06,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Pentabromoethane,75-95-6,4.43380854655804e-06,2.96537320805261e-06,14.9519410727723,7.81411776656886e-05,TOX21_HRE_BLA_Agonist_viability
"2,2',4,4',5-Pentabromodiphenyl ether",60348-60-9,0.000404806720300749,0.00763547513064046,0.530165724299588,0.00713428952087737,TOX21_MMP_fitc
"4,4'-Dibromodiphenyl ether",2050-47-7,3.43620162358248e-05,0.000123185394868036,2.78945537923839,0.000605594126909087,TOX21_MMP_fitc
"1,2,5,6,9,10-Hexabromocyclododecane",3194-55-6,0.00216259011858368,0.00375289975848348,5.76245105853179,0.0381133594064396,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability
"1,2-Dibromo-2,4-dicyanobutane",35691-65-7,2.10605905961507e-06,9.95173903218119e-06,2.11627239501021,3.71170593912021e-05,NVS_GPCR_hDRD1|NVS_GPCR_hORL1|NVS_TR_gDAT
"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",3322-93-8,2.05063645278309e-05,2.70858428567979e-05,7.57087923615579,0.00036140294670381,TOX21_MMP_ratio_down
"1,4-Butanediol diglycidyl ether",2425-79-8,0,0,0.645110143412394,0,TOX21_RT_HEK293_GLO_40hr_viability
4-(Diglycidylamino)phenyl glycidyl ether,5026-74-4,0,0,7.62065053061028,0,TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability
Cantharidin,56-25-7,1.10845213663951e-07,3.37461191083948e-05,0.0328468033043767,1.95352944164221e-06,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
"2E,4E-Hexadienoic acid",110-44-1,0.000200408146304423,0.000257392971897319,7.7860768624394,0.00353198123048912,APR_HepG2_MitoMass_72h_up
"(2,4,6-Trioxo-1,3,5-triazinane-1,3,5-triyl)triethane-2,1-diyl trisprop-2-enoate",40220-08-4,0,0,5.55548761892791,0,ATG_XTT_Cytotoxicity_up|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability
Diethylene glycol diacrylate,4074-88-8,0,0,20.318483085749,0,TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability
Diallyl phthalate,131-17-9,9.26665986230631e-05,0.000318561198603349,2.90891040808914,0.00163315061321289,NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX
"5,6,7,8-Tetrahydroquinoxaline",34413-35-9,3.30318736718574e-05,8.34616497786658e-05,3.9577307373453,0.00058215177360938,TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability
Mepanipyrim,110235-47-7,1.77352341862322e-06,2.53347417672745e-05,0.700036114405603,3.12564710662754e-05,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
3-Methylbut-3-en-1-ol,763-32-6,0.000346169602272519,0.000110861282640893,31.2254733145969,0.00610087244624864,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability
Methyl trans-styryl ketone,1896-62-4,0,0,11.4035274127695,0,BSK_3C_Proliferation_down|BSK_SAg_Proliferation_down
Diacetone alcohol,123-42-2,0.000648111964293122,0.0110080738025199,0.588760555134321,0.011422286645282,APR_HepG2_MitoMass_24h_dn
N-Acetyl-m-toluidine,537-92-8,2.21690427327902e-07,2.00478797257418e-07,11.0580485498049,3.90705888328443e-06,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
1-Acetyl-2-phenylhydrazine,114-83-0,2.21690427327902e-07,8.17308759116733e-07,2.71244404094584,3.90705888328443e-06,TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_TR_LUC_GH3_Antagonist_viability
5-Nitro-2-furanmethanediol diacetate,92-55-7,3.08149693985784e-05,2.45848203352994e-05,12.5341446381585,0.000543081184776536,TOX21_Aromatase_Inhibition_viability
Adefovir dipivoxil,142340-99-6,0,0,0.414304278567089,0,TOX21_CAR_Agonist_viabillity|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability
Triadimenol,55219-65-3,1.88436863228717e-06,0.00139877269211849,0.0134715857902061,3.32100005079177e-05,NVS_TR_gDAT|NVS_TR_hDAT
"2,6-Di-tert-butylphenol",128-39-2,2.64920060656843e-05,8.76859965359747e-06,30.2123567185731,0.000466893536552489,APR_HepG2_CellLoss_24h_dn|NCCT_HEK293T_CellTiterGLO
"4,4'-(Isopropylidenebis(4,1-phenyleneoxy))dianiline",13080-86-9,1.66267820495927e-05,2.42177597006801e-05,6.86553267316702,0.000293029416246332,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
2-Chloro-2-nitropropane,594-71-8,4.87718940121384e-06,0.00018061511881846,0.27003217854182,8.59552954322574e-05,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability
Hydroxyflutamide,52806-53-8,2.60486252110285e-05,0.00188213020369505,0.138399698171195,0.00045907941878592,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_72h_dn|TOX21_MMP_ratio_down
Esfenvalerate,66230-04-4,0.00022557000980614,0.0272235534489674,0.0828584006231915,0.00397543241374191,NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Isopropamide,7492-32-2,7.75916495647657e-07,2.15005101931201e-06,3.608828296065,1.36747060914955e-05,TOX21_RT_HEPG2_GLO_40hr_viability
Allethrin,584-79-2,1.88436863228717e-06,2.18298899678616e-05,0.863205739956257,3.32100005079177e-05,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX
Riboprine,7724-76-7,6.65071281983706e-07,4.48430270088501e-06,1.48310969697128,1.17211766498533e-05,TOX21_ARE_BLA_agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability
"2,2,4-Trimethyl-1,3-pentanediol",144-19-4,2.54943991427087e-06,6.40180022458153e-05,0.398237968201753,4.49311771577709e-05,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability
Imazapyr,81334-34-1,1.30797352123462e-05,0.0445044586439624,0.00293897187178136,0.000230516474113781,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|INTER_BURST_INTERVAL_AVG_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX
Deethylatrazine,6190-65-4,1.47424134173055e-05,0.0330404792368381,0.00446192481399258,0.000259819415738415,SH-S5Y5 neurite outgrowth
Oxadiazon,19666-30-9,1.00869144434195e-05,0.00698025862007052,0.0144506314055705,0.000177771179189442,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE
Bicalutamide,90357-06-5,2.29449592284379e-05,0.137887438985673,0.00166403549135624,0.000404380594419938,SH-S5Y5 viability
"2-Methyl-2,4-pentanediol",107-41-5,0.000790326373423971,0.00054702094789883,14.447826476476,0.013928664918909,APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_hDFCGF_Proliferation_down
meso-Hexestrol,84-16-2,3.12583502532342e-05,0.000200778644155645,1.55685632725971,0.000550895302543105,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a|NVS_GPCR_hOpiate_D1|NVS_GPCR_rOpiate_NonSelective|NVS_TR_gDAT
trans-Hex-3-en-1-ol,928-97-2,5.54226068319755e-07,9.89215969090536e-07,5.60268015921032,9.76764720821107e-06,TOX21_PR_BLA_Agonist_viability
Clomazone,81777-89-1,0,0,0.0488789124037467,0,NVS_TR_hDAT|SH-S5Y5 neurite outgrowth
"5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin",63612-50-0,2.28341140147739e-05,5.72200080960038e-05,3.99058210136266,0.000402427064978296,NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_bAdoR_NonSelective
"2,3-Dimethylphenol",526-75-0,0,0,0.149726139097127,0,ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_FLO_08hr_viability
Terbacil,5902-51-2,0,0,0.887543958494256,0,BSK_SAg_PBMCCytotoxicity_up
4-Chloro-3-methylphenol,59-50-7,1.88436863228717e-06,0.00315812575454988,0.00596673083575719,3.32100005079177e-05,SH-S5Y5 viability
Rimonabant,168273-06-1,2.33883400830937e-05,0.000791785329510143,0.295387388619128,0.000412194712186507,TOX21_RT_HEK293_GLO_40hr_viability
2-Amino-m-cresol,2835-97-4,3.32535640991853e-07,1.69596190799196e-08,196.074946863387,5.86058832492665e-06,TOX21_RT_HEK293_GLO_40hr_viability
"4,4'-Diamino-3,3'-dimethyldiphenylmethane",838-88-0,4.43380854655804e-07,1.30993077568575e-06,3.38476553788649,7.81411776656886e-06,APR_HepG2_MitoMass_72h_up|NCCT_MITO_basal_resp_rate_OCR_dn|NVS_TR_hDAT|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
4-Chloro-2-methylaniline,95-69-2,3.32535640991853e-07,9.05380285167767e-06,0.367288360967827,5.86058832492665e-06,ACEA_ER_AUC_viability|BSK_3C_Proliferation_down
Methylhydroquinone,95-71-6,1.10845213663951e-07,7.09114505795118e-08,15.6314971359473,1.95352944164221e-06,TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
"2-Methyl-1,3-benzenediol",608-25-3,2.21690427327902e-07,5.68588106123593e-06,0.389896350170423,3.90705888328443e-06,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down
Tiliquinol,5541-67-3,0,0,2.13586263652171,0,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability
2-Methyl-4-nitroaniline,99-52-5,0,0,16.1935867262736,0,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
"3,3'-Dimethylbenzidine",119-93-7,0.000309812372190743,0.00214971366844319,1.44117971029652,0.00546011478938999,ACEA_AR_antagonist_AUC_viability|BSK_SAg_Proliferation_down
Isophorone,78-59-1,2.43859470060692e-06,0.00931832748528296,0.00261698754895485,4.29776477161287e-05,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability
"3,5-Dimethylpyridine",591-22-0,4.17886455513095e-05,0.000462485256652406,0.903567085657759,0.000736480599499115,ACEA_ER_AUC_viability
4-Methylcatechol,452-86-8,1.10845213663951e-07,5.58868654068693e-08,19.8338577153992,1.95352944164221e-06,TOX21_SSH_3T3_GLI3_Agonist_viability
"3,4-Dinitrotoluene",610-39-9,2.66028512793482e-05,0.000204081907455247,1.30353795743417,0.000468847065994132,NVS_ENZ_rMAOAC
Diiodomethyl 4-methylphenyl sulfone,20018-09-1,8.20254581113237e-06,0.000186667978173705,0.439419009697498,0.000144561178681524,NVS_GPCR_hDRD1|NVS_TR_rVMAT2
"3,4-Diaminotoluene",496-72-0,1.44098777763136e-06,1.37250985854736e-05,1.04989247884637,2.53958827413488e-05,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX
C.I. Solvent Orange 7,3118-97-6,1.91762219638635e-05,0.000116299414175592,1.64886660004244,0.000337960593404103,BSK_SAg_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_PXR_viability
1-Phenyl-3-methyl-5-pyrazolone,89-25-8,6.65071281983706e-07,9.76601195042899e-07,6.8100600875723,1.17211766498533e-05,TOX21_MMP_rhodamine
"2,2-Dichloro-1-(3-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)ethanone",98730-04-2,0,0,3.14127675233068,0,ACEA_AR_agonist_AUC_viability|ACEA_ER_AUC_viability|BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Flopropione,2295-58-1,0,0,2.01549724460801,0,TOX21_MMP_ratio_down
Iopanoic acid,96-83-3,2.21690427327902e-05,0.000707883710049544,0.313173511666748,0.000390705888328443,ACEA_AR_agonist_AUC_viability
2-Ethylphenol,90-00-6,0,0,2.90693303691364,0,TOX21_RT_HEK293_FLO_40hr_viability
"2,2'-Methylenebis(ethyl-6-tert-butylphenol)",88-24-4,0.00566086506181798,0.145216556862728,0.389822289146351,0.0997667485846679,TOX21_MMP_rhodamine
Enefexine,67765-04-2,6.65071281983706e-07,2.17829285677983e-06,3.05317661908364,1.17211766498533e-05,TOX21_PR_BLA_Agonist_viability
Imazethapyr,81335-77-5,2.21690427327902e-07,0.000179134022814886,0.0123756740257541,3.90705888328443e-06,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION
Pyrimethamine,58-14-0,0,0,0.404722447982603,0,NVS_GPCR_hAdra2A|NVS_GPCR_hDRD1|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rCaBTZCHL|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_GPCR_g5HT4|NVS_GPCR_h5HT2A|NVS_GPCR_h5HT7|NVS_GPCR_p5HT2C
Valproic acid,99-66-1,2.21690427327902e-07,2.88150810818925e-08,76.935555620287,3.90705888328443e-06,%SiNS|NSDsd|#SiNS
6-Propyl-2-thiouracil,51-52-5,1.88436863228717e-06,0.00187845672170582,0.0100314721681529,3.32100005079177e-05,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION
MEHP,4376-20-9,1.95087576048554e-05,0.000312749657637317,0.623781901225256,0.00034382118172903,NCCT_MITO_basal_resp_rate_OCR_dn
gamma-Decanolactone,706-14-9,2.21690427327902e-07,2.20030596144192e-06,1.00754363807942,3.90705888328443e-06,ACEA_AR_antagonist_AUC_viability
5-Heptyldihydro-2(3H)-furanone,104-67-6,5.54226068319755e-07,2.42228286282225e-06,2.28803199174689,9.76764720821107e-06,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION
Carmofur,61422-45-5,1.10845213663951e-07,4.56825315147126e-07,2.42642449944465,1.95352944164221e-06,TOX21_ERb_BLA_Agonist_viability
N-Butylbenzenesulfonamide,3622-84-2,0.00736233909155963,0.0743989082671046,0.989576226727358,0.129753425513876,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
2-Butoxyethanol,111-76-2,0.00111510284945935,0.129529221309624,0.0860889024256411,0.0196525061829207,SH-S5Y5 neurite outgrowth
"3,6,9,12-Tetraoxahexadecan-1-ol",1559-34-8,1.10845213663951e-06,2.26473949880332e-06,4.89439132944523,1.95352944164221e-05,TOX21_PR_BLA_Antagonist_viability
Dibutyl butylphosphonate,78-46-6,0.000511550661059134,0.000362138783525178,14.1258181761018,0.00901553837317882,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability
Tributyl phosphate,126-73-8,0.00624058552928044,0.0299167823000294,2.08598152926169,0.109983707564457,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION
Propylparaben,94-13-3,0,0,0.713099042501998,0,NVS_GPCR_hAdoRA1|NVS_TR_hDAT
Oxibendazole,20559-55-1,0,0,0.0878313412227301,0,TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Albendazole oxide,54029-12-8,1.10845213663951e-07,4.8915834430569e-07,2.26603951367291,1.95352944164221e-06,TOX21_RT_HEK293_GLO_40hr_viability
4-(Diethylamino)salicylaldehyde,17754-90-4,0,0,5.33250859943809,0,TOX21_RXR_BLA_Agonist_viability
4-(Diethylamino)benzaldehyde,120-21-8,0,0,1.88355662383692,0,NVS_TR_rSERT
"N,N-Diethyl-p-phenylenediamine",93-05-0,1.10845213663951e-07,3.0321383285263e-07,3.65567799533159,1.95352944164221e-06,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_MMP_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_Agonist_viability
"N-Ethyl-N-(3-methylphenyl)ethane-1,2-diamine",19248-13-6,3.43620162358248e-06,1.56613918400925e-06,21.9405890527939,6.05594126909087e-05,TOX21_RT_HEPG2_FLO_24hr_viability
Cyanazine,21725-46-2,2.32774948694297e-06,1.4247367370057e-05,1.63381025173471,4.10241182744865e-05,NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1
Atrazine,1912-24-9,1.00869144434195e-05,5.42033140617306e-05,1.8609405380512,0.000177771179189442,NVS_GPCR_bAdoR_NonSelective|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth
N-Ethylperfluorooctanesulfonamide,4151-50-2,1.46315682036415e-05,1.17150829649413e-05,12.4895130896026,0.000257865886296772,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_ARE_BLA_agonist_viability
Ethyl 4-oxo-1-piperidinecarboxylate,29976-53-2,7.9143482556061e-05,0.00405793728719648,0.195033774439474,0.00139482002133254,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability
"Ethyl 4-(5-chloro-2,3-dihydro-2-oxo-1h-benzimidazol-2-yl)piperidine-1-carboxylate",53786-46-2,0,0,0.50224826054555,0,TOX21_CAR_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability
2-Ethoxyaniline,94-70-2,1.10845213663951e-07,1.03812282862885e-06,1.06774661540153,1.95352944164221e-06,TOX21_RT_HEK293_GLO_40hr_viability
2-Ethoxy-5-(1-propenyl)phenol,94-86-0,0,0,0.728521911778959,0,NVS_TR_hNET
Oxyfluorfen,42874-03-3,1.07519857254032e-05,5.25515188507498e-05,2.04598952809331,0.000189492355839295,TOX21_MMP_rhodamine
4-Ethoxyphenol,622-62-8,0,0,8.58972442780259,0,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability
Tralkoxydim,87820-88-0,2.10605905961507e-06,4.83213743986115e-05,0.435844196450585,3.71170593912021e-05,NVS_GPCR_hAdra2A|NVS_GPCR_rmAdra2B
Ethyl 4-nitrophenyl ethylphosphonate,546-71-4,0,0,6.61952013790233,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability
Paraoxon,311-45-5,1.5740020340281e-05,0.0856710169826791,0.00183726316024279,0.000277401180713195,SH-S5Y5 neurite outgrowth
Diazoxon,962-58-3,0,0,0.00467189774716212,0,SH-S5Y5 neurite outgrowth
Ethyl dichlorophosphate,1498-51-7,3.09258146122423e-05,0.000568521870924856,0.543968775764652,0.000545034714218178,TOX21_RT_HEK293_GLO_32hr_viability
Molinate,2212-67-1,1.06411405117393e-05,0.000176401335156382,0.603234692203765,0.000187538826397653,NVS_GPCR_hM2
Mabuterol hydrochloride,54240-36-7,2.21690427327902e-07,9.7557067432209e-07,2.27241791049071,3.90705888328443e-06,TOX21_AhR_LUC_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Proguanil hydrochloride,637-32-1,1.10845213663951e-07,8.22581132610505e-07,1.34752924993767,1.95352944164221e-06,TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability
2-Chloropropyldimethylamine hydrochloride,4584-49-0,9.75437880242769e-06,6.13182630286992e-06,15.9077872082943,0.000171910590864515,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down
Cycloguanil hydrochloride,152-53-4,3.29210284581935e-05,0.000199018192808626,1.65417181181271,0.000580198244167738,TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability
"(-)-2,5-Dimethoxy-4-ethylamphetamine hydrochloride",42011-76-7,2.21690427327902e-07,2.55566670841124e-07,8.67446551611258,3.90705888328443e-06,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability
"(+)-2,5-Dimethoxy-4-ethylamphetamine hydrochloride",50505-91-4,1.10845213663951e-07,2.18655855389921e-07,5.06939150869227,1.95352944164221e-06,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Irinotecan hydrochloride,100286-90-6,0,0,1.40323754720254,0,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Benzidine dihydrochloride,531-85-1,0,0,4.13775695063119,0,TOX21_ERb_BLA_Agonist_viability
N-(1-Naphthyl)ethylenediamine dihydrochloride,1465-25-4,3.32535640991853e-07,4.12062611721636e-07,8.07002701852732,5.86058832492665e-06,TOX21_ERb_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_00hr_viability
Clonidine hydrochloride,4205-91-8,1.10845213663951e-07,4.54933537411938e-08,24.3651444768253,1.95352944164221e-06,TOX21_PR_BLA_Antagonist_viability
"1,3-Dichloro-6,7,8,9,10,12-hexahydroazepino[2,1-b]quinazoline hydrochloride (1:1)",149062-75-9,1.10845213663951e-07,4.61825390919449e-06,0.240015416742828,1.95352944164221e-06,NVS_ENZ_hAChE|NVS_ENZ_rAChE|NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_hAdra2A|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rOpiate_NonSelective|NVS_GPCR_rmAdra2B|NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|NVS_TR_hNET
Dexchlorpheniramine hydrochloride,5502-69-2,2.77113034159878e-06,5.59841222992704e-06,4.94985047150572,4.88382360410554e-05,TOX21_PXR_viability
Clomipramine hydrochloride,17321-77-6,6.42902239250916e-05,8.33676928432732e-05,7.71164724996693,0.00113304707615248,ATG_XTT_Cytotoxicity_up|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability
Diphenhydramine hydrochloride,147-24-0,0.000378536404662393,0.00625159849409421,0.605503384486368,0.00667130304320816,NVS_ENZ_hES|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_gOpiateK|NVS_GPCR_hAdra2A|NVS_GPCR_hAdra2C|NVS_GPCR_hDRD1|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rOpiate_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rCaBTZCHL|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_TR_rNET|NVS_GPCR_h5HT2A|NVS_GPCR_h5HT7|NVS_GPCR_p5HT2C|NVS_GPCR_r5HT_NonSelective|NVS_TR_rSERT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Naftifine hydrochloride,65473-14-5,2.07280549551588e-05,0.000120938349116529,1.71393566280506,0.000365310005587094,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability
-Methyl-2H-isothiazol-3-one hydrochloride,26172-54-3,3.32535640991853e-07,3.22262955607297e-07,10.3187671808321,5.86058832492665e-06,TOX21_CASP3_CHO_viability
"L-3,4-Dihydroxyphenylalanine methyl ester hydrochloride",1421-65-4,7.75916495647657e-07,1.58532388687003e-06,4.89437207168801,1.36747060914955e-05,TOX21_Aromatase_Inhibition_viability
"R-(-)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",50505-92-5,1.10845213663951e-07,2.3685470539904e-07,4.67988227116726,1.95352944164221e-06,TOX21_ERb_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_TR_LUC_GH3_Antagonist_viability
"S-(+)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",50505-93-6,1.10845213663951e-07,3.30982214352325e-07,3.34897794677143,1.95352944164221e-06,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability
"4-Bromo-2,5-dimethoxyamphetamine hydrochloride",29705-96-2,1.10845213663951e-07,2.07807744475563e-07,5.33402708083315,1.95352944164221e-06,TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability
p-Anisidinium chloride,20265-97-8,2.21690427327902e-07,3.18736945235986e-06,0.695527865976651,3.90705888328443e-06,ACEA_ER_AUC_viability|NCCT_HEK293T_CellTiterGLO
1-Phenylcyclohexylamine hydrochloride,1934-71-0,0,0,8.01988935521013,0,TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
4-Chloroaniline hydrochloride,20265-96-7,2.50510182880529e-05,0.000199077874197431,1.25835271192464,0.000441497653811141,ACEA_ER_AUC_viability
C.I. Basic Orange 2,532-82-1,0,0,0.864668741834001,0,TOX21_MMP_ratio_down
Lindane,58-89-9,0.000152855549642588,0.000902690253802259,1.69333333331937,0.00269391710002461,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|MFR|BR|BD|IBI|#NS|NSDsd|#SiNS|LD movement pattern (pearson) 5dpf|b D1 distmoved 5dpf|percent scrunching Tail 12d|mean firing rate|number network spikes|percent affected 4dpf|a L1 distmoved 5dpf|LD movement pattern (spearman) 1dpf|LD movement pattern (spearman) 5dpf|e L3 distmoved 5dpf
Captan,133-06-2,1.06411405117393e-05,3.34868219621143e-05,3.17770988354113,0.000187538826397653,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_FXR_BLA_agonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
"o,p'-DDE",3424-82-6,1.3523116067002e-05,1.91666018515054e-05,7.05556267708449,0.00023833059188035,BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability
MON-4660,71526-07-3,0,0,1.89360426471797,0,ACEA_ER_AUC_viability
"1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane",53-19-0,1.1417057007387e-05,0.0268901590093376,0.00424581238192842,0.000201213532489148,TOX21_RT_HEK293_FLO_24hr_viability
"p,p'-DDD",72-54-8,1.28580447850183e-05,0.000118296719011283,1.08693164886441,0.000226609415230497,APR_HepG2_MitoMembPot_24h_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
"2,2'-Dichlorobiphenyl",13029-08-8,2.39425661514134e-05,5.41678192588741e-05,4.42007200566617,0.000421962359394718,TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability
Dieldrin,60-57-1,1.15279022210509e-05,0.159521110486656,0.000722656843716947,0.00020316706193079,SH-S5Y5 viability
Aldrin,309-00-2,1.09736761527312e-05,1.34314379084328e-05,8.1701424877536,0.000193399414722579,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_PPARd_BLA_Agonist_viability
Isodrin,465-73-6,1.30797352123462e-05,2.98593291369382e-05,4.38045180196819,0.000230516474113781,BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down
Endrin,72-20-8,1.05302952980753e-05,0.000318738740063571,0.330373875983043,0.00018558529695601,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION
Imazalil,35554-44-0,2.10605905961507e-06,2.44099784697497e-05,0.86278611930159,3.71170593912021e-05,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_GPCR_gOpiateK|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hOpiate_mu|NVS_GPCR_rOpiate_NonSelective|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_TR_rVMAT2|NVS_TR_hSERT|NVS_TR_rSERT|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Thiacloprid,111988-49-9,0,0,0.574328864227149,0,NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|SH-S5Y5 neurite outgrowth
Amoxapine,14028-44-5,0,0,1.34190478735089,0,TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Ticlatone,70-10-0,1.10845213663951e-07,3.46821180783503e-07,3.1960335701972,1.95352944164221e-06,TOX21_CASP3_CHO_viability
2-Chloro-N-phenylacetamide,587-65-5,3.32535640991853e-07,3.59325409971719e-07,9.25444267963197,5.86058832492665e-06,ACEA_ER_AUC_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_HSE_BLA_agonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability
"1,2-Bis(chloromethyl)benzene",612-12-4,0,0,19.8652868718203,0,TOX21_RORg_LUC_CHO_Antagonist_viability
"2-Chloro-N,N-bis(2-chloroethyl)ethanamine",555-77-1,1.10845213663951e-07,1.35505755835744e-06,0.818011109419691,1.95352944164221e-06,TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Tris(2-chloroethyl) phosphate,115-96-8,0.000905272859993488,0.00601950386154387,1.50389945885225,0.015954474949892,IBI|NSDsd
Tetramethylthiuram monosulfide,97-74-5,3.54704683724643e-06,5.49451073462985e-05,0.645561908704759,6.25129421325509e-05,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
"N,N-Dimethyl-4-nitrosoaniline",138-89-6,1.10845213663951e-07,9.30565488806893e-08,11.9115973026325,1.95352944164221e-06,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability
"N,N-Dimethyl-p-phenylenediamine",99-98-9,0,0,14.1021011256584,0,TOX21_AR_BLA_Antagonist_viability|TOX21_HDAC_Inhibition_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RXR_BLA_Agonist_viability
3-Dimethylaminophenol,99-07-0,0.000225791700233468,0.125960108996276,0.0179256513854036,0.00397933947262519,TOX21_RT_HEPG2_FLO_24hr_viability
Acetamiprid,135410-20-7,1.72918533315764e-05,0.000760397387923544,0.22740548042644,0.000304750592896186,NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|SH-S5Y5 neurite outgrowth
Clothianidin,210880-92-5,2.21690427327902e-07,2.87927124890845e-06,0.769953256095431,3.90705888328443e-06,NVS_GPCR_rmAdra2B|NVS_LGIC_hNNR_NBungSens|SH-S5Y5 neurite outgrowth
Theophylline,58-55-9,1.44098777763136e-06,1.73318854150657e-05,0.831408553150709,2.53958827413488e-05,NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a
N-Methyl-2-pyrrolidone,872-50-4,0.0121597199389354,2.105850637385,0.0577425564903078,0.214302179748151,SH-S5Y5 neurite outgrowth
Olanzapine,132539-06-1,0,0,1.96448276637505,0,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PXR_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Thiamethoxam,153719-23-4,2.77113034159878e-06,0.00400938526207686,0.00691160903844729,4.88382360410554e-05,SH-S5Y5 neurite outgrowth
5-Chloro-2-methyl-3(2H)-isothiazolone,26172-55-4,0.000166046130068599,0.0031695358997081,0.52388152500147,0.00292638710358004,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI
Aldoxycarb,1646-88-4,2.77113034159878e-06,1.41272252212643e-05,1.96155316999383,4.88382360410554e-05,ACEA_AR_antagonist_AUC_viability
Propoxur,114-26-1,0,0,1.58438348656833,0,NVS_ENZ_hAChE|NVS_ENZ_rAChE
Carbofuran,1563-66-2,0.00047608019268667,0.0558215928360402,0.0852860279506924,0.00839040895185331,NVS_ENZ_hAChE|NVS_ENZ_rAChE
3-Hydroxycarbofuran,16655-82-6,1.10845213663951e-07,0.0105933590624766,0.000104636511431565,1.95352944164221e-06,SH-S5Y5 neurite outgrowth
Oxamyl,23135-22-0,2.77113034159878e-06,1.02463975905578e-05,2.70449230288742,4.88382360410554e-05,APR_HepG2_MitoMass_72h_up|NVS_ENZ_hAChE|NVS_ENZ_rAChE
Aldicarb,116-06-3,2.88197555526273e-06,2.08685852311632e-05,1.38101146931563,5.07917654826976e-05,APR_HepG2_MitoMembPot_72h_dn|NVS_ENZ_rAChE|#SiNS|r|percent affected 4dpf|LD movement pattern (pearson) 5dpf|LD movement pattern (spearman) 4dpf|mean correlation|a L1 distmoved 4dpf|b D1 distmoved 4dpf|number network spikes|b D1 distmoved 5dpf|percent affected 4dpf|LD movement pattern (spearman) 5dpf
"1,1,3-Trimethyl-2-thiourea",2489-77-2,5.54226068319755e-07,1.42352843910688e-06,3.89332628062896,9.76764720821107e-06,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
N-Methyl-4-nitroaniline,100-15-2,0,0,13.1974008034216,0,TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability
(N-6)-Methyladenine,443-72-1,3.33644093128493e-05,0.000795402662012855,0.419465648108556,0.000588012361934307,TOX21_MMP_ratio_down
Dimethyl isophthalate,1459-93-4,0,0,2.87449139914105,0,TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_00hr_ctrl_viability
Methylparaben,99-76-3,0,0,2.24165293422497,0,ACEA_AR_antagonist_AUC_viability
"Methyl 3-amino-5,6-dichloropyrazine-2-carboxylate",1458-18-0,0.000160836405026393,0.00346840315373042,0.463718887042892,0.00283457121982285,TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability
Cyclobendazole,31431-43-3,2.21690427327902e-07,1.03760204707228e-05,0.2136565053562,3.90705888328443e-06,TOX21_CASP3_CHO_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
2-Methoxy-4-vinylphenol,7786-61-0,2.21690427327902e-07,6.13608745879592e-07,3.61289549434493,3.90705888328443e-06,NVS_TR_hNET
Eugenol,97-53-0,3.32535640991853e-07,0.000114939573165249,0.0289313446913331,5.86058832492665e-06,BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX
2-Methoxy-4-nitroaniline,97-52-9,0,0,1.13581576672524,0,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|NCCT_HEK293T_CellTiterGLO|TOX21_CAR_Agonist_viabillity
"3,3'-Dimethoxybenzidine",119-90-4,0.000399375304831216,0.0006511206493197,6.13366056273117,0.0070385665782369,NVS_GPCR_r5HT1_NonSelective
Epirizole,18694-40-1,1.10845213663951e-07,1.66045561908079e-07,6.67559026511735,1.95352944164221e-06,TOX21_PR_BLA_Agonist_viability
"4'-Chloro-2',5'-dimethoxyacetoacetanilide",4433-79-8,1.10845213663951e-07,6.90968424422488e-07,1.60420085413593,1.95352944164221e-06,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_p53_BLA_p4_viability
(E)-Anethole,4180-23-8,0,0,0.27520846407751,0,NUMBER_OF_SPIKES|NUMBER_OF_SPIKES_PER_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION
Chlorotrianisene,569-57-3,4.81068227301547e-05,7.51020867990853e-05,6.40552410465653,0.000847831777672721,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability
4-Methoxyaniline,104-94-9,2.21690427327902e-07,2.9249917851557e-07,7.57918119472946,3.90705888328443e-06,TOX21_ERR_viability
6-Methoxy-2-benzothiazolamine,1747-60-0,3.32535640991853e-07,9.40349915321213e-06,0.353629681434344,5.86058832492665e-06,TOX21_RT_HEK293_GLO_32hr_viability
Brucine,357-57-3,4.43380854655804e-06,5.22269369047225e-06,8.48950524256598,7.81411776656886e-05,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
UK-333747,197077-55-7,0,0,2.09104935007564,0,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Fluvoxamine,54739-18-3,0,0,2.50730574266684,0,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability
Ethylene glycol dimethyl ether,110-71-4,3.10366598259063e-06,8.26696194465417e-05,0.375430055607987,5.4698824365982e-05,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Dicrotophos,141-66-2,0.000198856313313128,0.000666346807325693,2.98427652277971,0.00350463181830613,NVS_ENZ_hES
Difenzoquat metilsulfate,43222-48-6,1.68484724769206e-05,0.000149778924051857,1.12488940507326,0.000296936475129617,NCCT_MITO_max_resp_rate_OCR_dn|NVS_ENZ_hES|NVS_GPCR_gOpiateK|NVS_GPCR_hAdra2A|NVS_GPCR_hAdra2C|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rNaCh_site2|NVS_TR_hNET|NVS_GPCR_g5HT4|NVS_GPCR_h5HT7|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Piragliatin,625114-41-2,3.32535640991853e-07,7.65817354553993e-07,4.34223172162924,5.86058832492665e-06,APR_HepG2_MitoMass_72h_up
4-Chlorophenyl methyl sulfone,98-57-7,2.51618635017169e-05,0.450625660277935,0.000558376180490868,0.000443451183252783,TOX21_RT_HEPG2_FLO_16hr_ctrl_viability
3-Methyl-4-(methylthio)phenol,3120-74-9,1.33014256396741e-06,2.96997116260306e-06,4.47863797708257,2.34423532997066e-05,NVS_ENZ_rMAOAC|NVS_TR_gDAT
Metribuzin,21087-64-9,2.21690427327902e-07,9.74759162221539e-07,2.27430975691119,3.90705888328443e-06,ACEA_AR_agonist_AUC_viability
1-Hexyl-3-methylimidazolium tetrafluoroborate,244193-50-8,7.78133399920936e-05,0.000142137512005462,5.4745111894954,0.00137137766803283,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability
1-Hexyl-3-methylimidazolium hexafluorophosphate,304680-35-1,0,0,1.22830978320416,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
1-Ethyl-3-methylimidazolium hexafluorophosphate,155371-19-0,6.65071281983706e-07,0.000126986344376936,0.0523734489127086,1.17211766498533e-05,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability
Tralopyril,122454-29-9,1.5850865553945e-05,0.000569619069596923,0.278271329033304,0.000279354710154837,ACEA_ER_AUC_viability|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability
Tetraconazole,112281-77-3,1.11953665800591e-05,6.23739108150587e-05,1.79487969148733,0.000197306473605864,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_IC_rCaBTZCHL|NVS_IC_rCaDHPRCh_L|NVS_TR_hDAT
Diflubenzuron,35367-38-5,2.10605905961507e-06,1.04558652352519e-05,2.01423699735007,3.71170593912021e-05,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
2-(Thiocyanomethylthio)benzothiazole,21564-17-0,3.30318736718574e-05,0.00014121937980936,2.33904678780271,0.00058215177360938,APR_HepG2_MitoMass_1h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hAdra2A|NVS_GPCR_hDRD1|NVS_TR_hNET|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
"1,3-Diphenylguanidine",102-06-7,1.45207229899776e-05,0.000288148125177038,0.503932586098073,0.00025591235685513,NVS_GPCR_hM4|NVS_GPCR_rAdra1A|NVS_GPCR_rmAdra2B|NVS_GPCR_h5HT7|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION
"1,3-Diiminobenz(f)isoindoline",65558-69-2,4.43380854655804e-07,3.67122503548484e-06,1.20771908659979,7.81411776656886e-06,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
Indole,120-72-9,1.88436863228717e-06,1.69154291516887e-05,1.11399398465693,3.32100005079177e-05,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability
Phenothiazine,92-84-2,7.20493888815682e-06,3.58704207351613e-05,2.00860172267071,0.000126979413706744,NVS_ENZ_rMAOAC|TOX21_MMP_rhodamine|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Guanabenz,5051-62-7,1.21929735030346e-06,1.0329102591435e-05,1.18044848476432,2.14888238580644e-05,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
6-Aminonicotinamide,329-89-5,5.16538695674012e-05,0.000740897708372137,0.697179502429458,0.000910344719805272,CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount_loss|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI
2-Benzimidazolylurea,24370-25-0,3.29210284581935e-05,4.04332057321332e-11,8142077.25113183,0.000580198244167738,TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_FLO_16hr_viability
"2-Bromo-4,6-dinitroaniline",1817-73-8,2.40534113650774e-05,3.25568522257342e-05,7.38812560818292,0.000423915888836361,TOX21_SSH_3T3_GLI3_Antagonist_viability
"4-Nitro-1,2-phenylenediamine",99-56-9,1.10845213663951e-07,1.48793437482183e-07,7.44960366126523,1.95352944164221e-06,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_PXR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability
"4-Chloro-1,2-diaminobenzene",95-83-0,0,0,3.88127934669865,0,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability
2-Amino-5-nitrophenol,121-88-0,0,0,2.0208840650667,0,BSK_hDFCGF_Proliferation_down
2-Amino-4-nitrophenol,99-57-0,0,0,11.0818820742368,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability
3-(Trifluoromethyl)aniline,98-16-8,4.04585029873421e-05,4.86851088465604e-05,8.3102418677658,0.000713038246199409,TOX21_RT_HEK293_FLO_24hr_viability
"3,4-Dichloroaniline",95-76-1,0,0,1.19508694416682,0,ACEA_AR_agonist_AUC_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
2-Amino-4-chlorophenol,95-85-2,0,0,1.76704456198024,0,TOX21_MMP_ratio_down
"4-Chloro-1,3-diaminobenzene",5131-60-2,1.10845213663951e-07,6.15816345398358e-07,1.79997193144082,1.95352944164221e-06,TOX21_VDR_BLA_Agonist_viability
"1,3-Benzenediamine",108-45-2,1.82894602545519e-05,0.000110535562311396,1.65462226564041,0.000322332357870965,NCCT_MITO_inhib_resp_rate_OCR_up|NVS_ENZ_rMAOAC
"4-Nitro-1,3-benzenediamine",5131-58-8,0,0,7.35565281052755,0,TOX21_Aromatase_Inhibition_viability|TOX21_PXR_viability
4-Nitroaniline,100-01-6,1.10845213663951e-07,3.00731902371872e-07,3.6858481853676,1.95352944164221e-06,ACEA_AR_antagonist_AUC_viability|TOX21_ERR_viability
C.I. Azoic Diazo Component 112,92-87-5,7.75916495647657e-07,2.58316802650455e-06,3.00373993362561,1.36747060914955e-05,NVS_TR_gDAT|NVS_TR_hNET|NVS_TR_rNET
4-Biphenylamine,92-67-1,0,0,1.36230142978172,0,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Dapsone,80-08-0,1.25255091440265e-05,0.000349422041586493,0.3584636243082,0.00022074882690557,NVS_TR_gDAT|NVS_TR_hDAT|NVS_GPCR_h5HT6
"4,4'-Diaminobiphenyl methane",101-77-9,9.86522401609164e-06,9.72079198278504e-05,1.01485805205609,0.000173864120306157,NVS_TR_hDAT
4-Chloroaniline,106-47-8,0.000369003716287293,0.00400246602032453,0.921940909463045,0.00650329951122693,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|BSK_hDFCGF_Proliferation_down
"1,4-Diaminoanthraquinone",128-95-0,0.000202514205364038,0.549092632333327,0.00368816103948563,0.00356909828988033,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
"N-Phenyl-1,4-benzenediamine",101-54-2,0,0,3.98956481137279,0,TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PGC_ERR_viability|TOX21_TR_LUC_GH3_Antagonist_viability
4-Aminophenol,123-30-8,1.10845213663951e-07,8.4248617612577e-08,13.1569177993733,1.95352944164221e-06,TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_p53_BLA_p5_viability
"4,4'-Oxydianiline",101-80-4,0.00095526405135593,0.0730082350700271,0.130843328898401,0.0168355167280726,NVS_TR_gDAT|NVS_TR_hDAT
2-Aminodiphenylamine,534-85-0,0,0,3.32236350949437,0,TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability
"1,5-Naphthalenediamine",2243-62-1,3.34752545265132e-05,0.00100004113411509,0.334738776081792,0.000589965891375949,NVS_TR_hDAT
1-Naphthylamine,134-32-7,1.10845213663951e-07,5.93524939276715e-07,1.86757465994655,1.95352944164221e-06,BSK_3C_Proliferation_down
2-Naphthylamine,91-59-8,1.10845213663951e-07,2.56615664616161e-06,0.431950301357286,1.95352944164221e-06,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_24h_dn|NVS_TR_hNET|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG
"6-Phenyl-1,3,5-triazine-2,4-diamine",91-76-9,2.21690427327902e-06,9.95140763034892e-05,0.222772933802662,3.90705888328443e-05,NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a
2-Amino-5-nitrothiazole,121-66-4,5.54226068319755e-07,5.64047676606962e-07,9.82587272859116,9.76764720821107e-06,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity
"4,4'-Diaminodicyclohexylmethane",1761-71-3,9.97606922975559e-07,1.94482687949317e-06,5.12954100693806,1.75817649747799e-05,TOX21_PR_BLA_Agonist_viability
Praziquantel,55268-74-1,0,0,15.1696390176844,0,TOX21_SSH_3T3_GLI3_Antagonist_viability
Thidiazuron,51707-55-2,1.18604378620428e-05,0.000154997215308945,0.765203286936622,0.000209027650255717,APR_HepG2_MitoMembPot_1h_dn|NVS_LGIC_bGABARa5|NVS_LGIC_rGABARa6|TOX21_MMP_ratio_down|NVS_GPCR_h5HT5A
"Bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate",5493-45-8,0,0,5.19840223675956,0,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Caprolactam,105-60-2,0.00429746893375138,0.00968977311725086,4.43505630291852,0.0757383364524687,TOX21_CAR_Antagonist_viability|TOX21_PR_BLA_Antagonist_viability
"1,1'-Disulfanediyldiazepan-2-one",23847-08-7,4.43380854655804e-07,2.7296543309491e-07,16.2431136290301,7.81411776656886e-06,TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
1-Phenyl-3-pyrazolidinone,92-43-3,1.10845213663951e-07,1.91460811168096e-07,5.78944657069443,1.95352944164221e-06,TOX21_ERb_BLA_Antagonist_viability
"cis-1,2,3,6-Tetrahydrophthalimide",1469-48-3,3.32535640991853e-07,7.67625391066146e-07,4.33200418930903,5.86058832492665e-06,TOX21_PR_BLA_Antagonist_viability
"5,5-Diphenylhydantoin",57-41-0,0,0,1.4249809968104,0,NVS_TR_hDAT|BD
"1H-Benzo[de]isoquinoline-1,3(2H)-dione",81-83-4,4.62224540978676e-05,0.000431488833452769,1.07123175652069,0.000814621777164804,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
Thiouracil,141-90-2,2.66028512793482e-05,0.000113476478260431,2.34434939180031,0.000468847065994132,MFR|BR|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI
N-Nitrosomorpholine,59-89-2,0.000407467005428684,0.00978154848124574,0.416566974247405,0.00718117422747678,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Triphenylphosphine oxide,791-28-6,6.20733196518126e-06,3.52602337395629e-05,1.76043415112603,0.000109397648731964,NVS_GPCR_gOpiateK
Chlorpheniramine maleate,113-92-8,1.55183299129531e-06,1.07181515213804e-05,1.44785505989512,2.7349412182991e-05,NVS_ENZ_hES|NVS_GPCR_hDRD1|NVS_GPCR_hM2|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET
Perfluorooctanoic acid,335-67-1,0.000506451781230592,0.000578986247258463,8.74721608032443,0.00892567601886328,TOX21_ERb_BLA_Agonist_viability|TOX21_HRE_BLA_Agonist_viability
Perfluoroheptanoic acid,375-85-9,2.16148166644704e-05,5.74173565029411e-05,3.76450919738237,0.000380938241120232,APR_HepG2_MitoMass_72h_dn
4-Nitrobenzoic acid,62-23-7,1.10845213663951e-07,3.86304511305439e-06,0.286937404094433,1.95352944164221e-06,NVS_LGIC_rGABAR_NonSelective
"2,4-Dichlorophenoxybutyric acid",94-82-6,9.53268837509979e-06,3.94768791410054e-05,2.41475227589559,0.00016800353198123,NCCT_MITO_basal_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG
4-Chlorophenoxyacetic acid,122-88-3,2.21690427327902e-06,0.000248929366321115,0.0890575630365463,3.90705888328443e-05,ACEA_AR_antagonist_AUC_viability
"2-(1-Chlorocyclopropyl)-1-(2-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)-2-propanol",120983-64-4,0,0,6.47364569062271,0,BSK_3C_Proliferation_down|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability
Prothioconazole,178928-70-6,0,0,5.80184226015031,0,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_CASM3C_SRB_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down
2-Hydroxy-3-phenoxypropyl prop-2-enoate,16969-10-1,0,0,0.141140534298161,0,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability
2-Phenylphenol,90-43-7,0.00368560335432637,5.58708368764415,0.00659664963042722,0.0649548539346037,SH-S5Y5 viability
"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]",41481-66-7,6.35143074294439e-05,0.000338976916855077,1.8737059743982,0.00111937237006099,APR_HepG2_MitoMass_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a|NVS_GPCR_hOpiate_mu|NVS_GPCR_rOpiate_NonSelectiveNa|NVS_IC_rCaDHPRCh_L|NVS_TR_gDAT|NVS_TR_hNET|NVS_GPCR_g5HT4|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION
"2,3,4,6-Tetrachlorophenol",58-90-2,2.33883400830937e-05,3.71863955193776e-05,6.28948833476107,0.000412194712186507,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down
"((3,4-Dihydroxyphenyl)methylene)-Propanedinitrile",118409-57-7,0,0,6.21260984077033,0,TOX21_MMP_rhodamine
Quinalizarin,81-61-8,4.57790732432118e-05,6.58485770774601e-05,6.95217349789657,0.000806807659398235,BSK_3C_SRB_down
Clioquinol,130-26-7,2.37208757240855e-05,7.95179968761357e-05,2.98308265499133,0.000418055300511434,TOX21_AR_BLA_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARg_BLA_antagonist_viability
"4,6-Dichloro-1,3-benzenediol",137-19-9,0,0,2.70475854805243,0,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
4-Nitrophenol,100-02-7,0,0,16.7587531234721,0,TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability
Nitroxoline,4008-48-4,0,0,1.90648261990332,0,TOX21_AR_BLA_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability
Cloxyquin,130-16-5,2.29449592284379e-05,6.52719689915343e-05,3.51528528753496,0.000404380594419938,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability
Hydroquinone,123-31-9,6.90565681126415e-05,0.0132128320594482,0.0522647739727084,0.0012170488421431,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|AREA_UNDER_CROSS_CORRELATION
C.I. Solvent Yellow 14,842-07-9,0.00217034928354016,0.00699098969365014,3.10449504096891,0.0382501064673546,ATG_FoxA2_CIS_up|BSK_SAg_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability
1-Naphthol,90-15-3,5.09887982854175e-06,1.18373907332981e-05,4.30743560250894,8.98623543155419e-05,NVS_ENZ_rMAOAC|TOX21_MMP_fitc
2-Naphthalenol,135-19-3,0.000538153512338482,0.00328560254211049,1.63791421951117,0.00948438543917295,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC|NVS_TR_hNET|NVS_TR_rNET|NVS_GPCR_p5HT2C
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,77439-76-0,2.21690427327902e-07,7.43173817009352e-06,0.298302257498816,3.90705888328443e-06,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability
Bronopol,52-51-7,5.16538695674012e-05,0.000266030117637536,1.94165495343573,0.000910344719805272,APR_HepG2_MitoMembPot_24h_dn|NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_rOpiate_NonSelective|NUMBER_OF_SPIKES|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
1-Hydroxybenzotriazole,2592-95-2,7.98085538380447e-06,0.00442766216528412,0.0180249871961321,0.000140654119798239,TOX21_AR_BLA_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability
CP-544439,230954-09-3,0,0,12.1460601966672,0,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn
6-Mercaptopurine,50-44-2,1.33014256396741e-06,2.89228797511374e-05,0.459892851407752,2.34423532997066e-05,TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability
2-Mercaptobenzimidazole,583-39-1,5.6531058968615e-06,4.41590612774439e-06,12.8016894683155,9.9630001523753e-05,TOX21_PR_BLA_Antagonist_viability
Benzothiazole,95-16-9,0,0,0.0134207699457019,0,SH-S5Y5 neurite outgrowth
2-Mercaptobenzothiazole,149-30-4,0,0,14.207620837123,0,APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn|NVS_TR_hNET
